title: Targeting Waldenstrom macroglobulinemia with histone deacetylase inhibitors.
authors.affiliation: Department of Medicine, Division of Hematology/Oncology, Virginia Commonwealth University Health Sciences Center/Massey Cancer Center, Richmond, VA, USA. stgrant@vcu.edu
authors.forename: Steven
authors.initials: S
authors.lastname: Grant
mesh_terms: D017209:Apoptosis / Q000187:drug effects*; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism*; D056572:Histone Deacetylase Inhibitors / Q000494:pharmacology*; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology*; D013312:Stress, Physiological / Q000187:drug effects*; D000077337:Vorinostat; D008258:Waldenstrom Macroglobulinemia / Q000201:enzymology*; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism*
chemical_list: D056572:Histone Deacetylase Inhibitors; D006877:Hydroxamic Acids; D000077337:Vorinostat; D048049:Extracellular Signal-Regulated MAP Kinases; D048051:p38 Mitogen-Activated Protein Kinases